Table 1.
Relationship between clinical characteristics and Fibrinogen–Albumin Ratio Index.
| Variables | Total (n = 357) | FARI-low (n = 243) | FARI-high (n = 114) | χ2 | P-value |
|---|---|---|---|---|---|
| Gender | 0.795 | 0.373 | |||
| Male (%) | 185 (51.8) | 122 (50.2) | 63 (55.3) | ||
| Female (%) | 172 (48.2) | 121 (49.8) | 51 (44.7) | ||
| ECOG score | 3.621 | 0.164 | |||
| 0 (%) | 267 (74.8) | 189 (77.8) | 78 (68.4) | ||
| 1 (%) | 78 (21.8) | 47 (19.3) | 31 (27.2) | ||
| 2 (%) | 12 (3.4) | 7 (2.9) | 5 (4.4) | ||
| Age, years | 60.88 ± 12.05 | 59.47 ± 12.56 | 62.82 ± 10.72 | −2.466 | 0.014 |
| BMI (kg/m2) | 0.533 | 0.465 | |||
| <18.5 (%) | 15 (4.2) | 12 (4.9) | 3 (2.6) | ||
| ≥18.5 (%) | 342 (95.8) | 231 (95.1) | 111 (97.4) | ||
| Tumor size | 32.394 | <0.001 | |||
| ≤ 2 (%) | 82 (22.9) | 67 (27.6) | 15 (13.1) | ||
| >2, ≤ 5 (%) | 142 (39.8) | 105 (43.2) | 37 (32.6) | ||
| >5, ≤ 10 (%) | 80 (22.4) | 51 (21.0) | 29 (25.4) | ||
| >10 (%) | 53 (14.9) | 20 (8.2) | 33 (28.9) | ||
| Tumor location | 4.126 | 0.248 | |||
| stomach (%) | 221 (61.9) | 158 (65.0) | 63 (55.3) | ||
| Intestine (%) | 75 (21.0) | 45 (18.5) | 30 (26.3) | ||
| Colorectum (%) | 27 (7.6) | 19 (7.8) | 8 (7.0) | ||
| E-GIST (%) | 34 (9.5) | 21 (8.7) | 13 (11.4) | ||
| Mitotic index (per 50 HPF) | 10.462 | 0.005 | |||
| ≤ 5 (%) | 211 (59.1) | 157 (64.6) | 54 (47.4) | ||
| >5, ≤ 10 (%) | 60 (16.8) | 38 (15.6) | 22 (19.3) | ||
| >10 (%) | 86 (24.1) | 48 (19.8) | 38 (33.3) | ||
| NIH risk category | 22.978 | <0.001 | |||
| Very low (%) | 64 (17.9) | 54 (22.2) | 10 (8.8) | ||
| Low (%) | 101 (28.3) | 75 (30.9) | 26 (22.8) | ||
| Intermediate (%) | 61 (17.1) | 44 (18.1) | 17 (14.9) | ||
| High (%) | 131 (36.7) | 70 (28.8) | 61 (53.5) | ||
| Surgery | 15.342 | <0.001 | |||
| Open (%) | 184 (51.5) | 108 (44.4) | 76 (66.7) | ||
| Laparoscopy (%) | 173 (48.5) | 135 (55.6) | 38 (33.3) | ||
| Clavien–Dindo grade | 0.009 | 0.925 | |||
| <3 (%) | 314 (88.0) | 214 (88.1) | 100 (87.7) | ||
| ≥3 (%) | 43 (12.0) | 29 (11.9) | 14 (12.3) | ||
| NLR | 6.111 | 0.013 | |||
| Low (%) | 96 (26.9) | 75 (30.9) | 21 (18.4) | ||
| High(%) | 261 (73.1) | 168 (69.1) | 93 (81.6) | ||
| PLR | 15.270 | <0.001 | |||
| Low (%) | 147 (41.2) | 117 (48.1) | 30 (26.3) | ||
| High (%) | 210 (58.8) | 126 (51.9) | 84 (73.7) | ||
| PNI | 38.956 | <0.001 | |||
| Low (%) | 147 (41.2) | 73 (30.0) | 74 (64.9) | ||
| High (%) | 210 (58.8) | 170 (70.0) | 40 (35.1) |
FARI, fibrinogen–albumin ratio index; ECOG, Eastern Cooperative Oncology Group; BMI, body mass index; NIH, National Institute of Health; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PNI, prognostic nutritional index.